These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24311524)

  • 21. The challenge of orbital decompression in a patient with multiple autoimmune diseases and graves' orbitopathy: a case report and review of literature.
    Sellari-Franceschini S; Bartalena L; Seccia V
    Orbit; 2010 Feb; 29(1):48-50. PubMed ID: 20302412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of genetics in Graves' disease and thyroid orbitopathy.
    Kim N; Hatton MP
    Semin Ophthalmol; 2008; 23(1):67-72. PubMed ID: 18214794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Management of Graves' orbitopathy: evidence-based recommendations].
    Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
    Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid-associated orbitopathy: who and how to treat.
    Dickinson J; Perros P
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):373-88, ix. PubMed ID: 19328417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy.
    Bartalena L; Baldeschi L; Dickinson AJ; Eckstein A; Kendall-Taylor P; Marcocci C; Mourits MP; Perros P; Boboridis K; Boschi A; Currò N; Daumerie C; Kahaly GJ; Krassas G; Lane CM; Lazarus JH; Marinò M; Nardi M; Neoh C; Orgiazzi J; Pearce S; Pinchera A; Pitz S; Salvi M; Sivelli P; Stahl M; von Arx G; Wiersinga WM
    Thyroid; 2008 Mar; 18(3):333-46. PubMed ID: 18341379
    [No Abstract]   [Full Text] [Related]  

  • 26. [Combined idiopathic orbital inflammation and Graves' orbitopathy].
    Ciechanowski PP; Töteberg-Harms M; Pangalu A; Chaloupka K
    Klin Monbl Augenheilkd; 2012 Apr; 229(4):466-7. PubMed ID: 22496035
    [No Abstract]   [Full Text] [Related]  

  • 27. [Thyroid associated orbitopathy: from diagnosis to treatment].
    Hamédani M; Obéric A
    Rev Med Suisse; 2013 Jan; 9(368):66-71. PubMed ID: 23367708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Graves' orbitopathy.
    Bhatnagar A; Tsirbas A; Douglas RS; Goldberg RA; Hoyama E
    Ophthalmology; 2007 Feb; 114(2):392.e1-2. PubMed ID: 17270688
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluating Graves' orbitopathy.
    Dolman PJ
    Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):229-48. PubMed ID: 22632361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined thyroid eye clinic: the importance of a multidisciplinary health care in patients with Graves' orbitopathy.
    Wiersinga WM
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():250-3. PubMed ID: 20467372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Graves' orbitopathy].
    Eckstein A; Esser J
    Klin Monbl Augenheilkd; 2011 May; 228(5):432-8. PubMed ID: 21534176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Graves' Orbitopathy].
    Eckstein A; Esser J; Mattheis S; Berchner-Pfannschmidt U
    Klin Monbl Augenheilkd; 2016 Dec; 233(12):1385-1407. PubMed ID: 27871109
    [No Abstract]   [Full Text] [Related]  

  • 33. [Management of patient with Gaves' orbitopathy].
    Di Fiore A; Paone L; Rendina R; D'Armiento E; Coccaro C; Alessandrini S; Marenco M; Ulisse S
    Clin Ter; 2012 Nov; 163(6):e463-74. PubMed ID: 23306763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
    Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
    Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical practice. Graves' ophthalmopathy.
    Bartalena L; Tanda ML
    N Engl J Med; 2009 Mar; 360(10):994-1001. PubMed ID: 19264688
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment options for Graves' orbitopathy.
    Marcocci C; Altea MA; Leo M
    Expert Opin Pharmacother; 2012 Apr; 13(6):795-806. PubMed ID: 22404364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid orbitopathy.
    Chang EL; Rubin PA
    Ophthalmology; 2006 Apr; 113(4):718-9; author reply 719-20. PubMed ID: 16581440
    [No Abstract]   [Full Text] [Related]  

  • 38. Update on thyroid eye disease.
    Stemberger K; Kahaly GJ; Pitz S
    Compr Ophthalmol Update; 2006; 7(6):287-98. PubMed ID: 17244445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The EUGOGO consensus statement on the management of Graves' orbitopathy: equally applicable to North American clinicians and patients.
    Bahn R
    Thyroid; 2008 Mar; 18(3):281-2. PubMed ID: 18341375
    [No Abstract]   [Full Text] [Related]  

  • 40. Spontaneous interblink time distributions in patients with Graves' orbitopathy and normal subjects.
    Garcia D; Pinto CT; Barbosa JC; Cruz AA
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3419-24. PubMed ID: 21345986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.